ETEST Imipenem/Relebactam (IPR) (0.002/4-32/4 ug/mL)
FDA 510(k) clearance K191953 · decided 2019-08-22
Clearance details
- K-number
- K191953
- Device name
- ETEST Imipenem/Relebactam (IPR) (0.002/4-32/4 ug/mL)
- Applicant
- Biomerieux S.A.
- Decision
- Substantially Equivalent
- Date received
- 2019-07-22
- Decision date
- 2019-08-22
- Days to decision
- 31 days
- Clearance type
- Traditional
- Product code
- JWY
- Device class
- 2
- Regulation number
- 866.1640
- Medical specialty
- Microbiology
- Advisory committee
- Microbiology
- Location
- Marcy-L'Etoile, FR
- Third-party review
- No
- Expedited review
- No
+ Add to Predicate Builder ◉ Watch Biomerieux S.A.
The Builder collects up to 8 candidate devices side by side with yours, then exports the substantial-equivalence comparison scaffold. How it works
Need this as data, not a web page?
Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.
Similar devices under this product code
Devices cleared under the same product code - the starting set for predicate research.
Recalls involving this device
| Record | Firm | Date |
|---|---|---|
| ETEST CLINICAL IMIPENEM RELEBACTAM IPR US S30, CATALOG 420927 recall (Z-0849-2023) | Biomerieux Inc | 2023-01-04 |